The gap between the trailing and forward P/E implies the market expects earnings to decline from current levels, consistent with a nitrogen cycle that may be normalizing from elevated spreads. Relative to peers such as Nutrien at 15.08 and The Andersons at 19.69, CF's multiples appear discounted, which may reflect investor caution about natural gas spread durability rather than a mispricing of the franchise. Investors should monitor whether the forward discount narrows as reported quarterly EPS resolves against the $3.69 estimate.

The operating margin of 37.7% in 2026Q3 and net margin of 23.4% indicate efficient conversion at the operating line, but the net margin decline from the 32.7% peak in 2026Q2 points to meaningful below-the-line drag. The recurrence of gross margins in the high-30s suggests that the 2026Q2 outlier reflects a temporary dislocation rather than a durable earnings base. Analysts should treat trailing margin levels with caution when extrapolating forward earnings power.

ROE of 4.9% in 2026Q3 and ROIC of 5.3% appear modest for a business reporting a 33.4% operating margin, suggesting that the large, asset-heavy base of plant and equipment dilutes returns. The gap between margin strength and return metrics may indicate that capital intensity, rather than pricing, is the binding constraint on value creation. Investors should monitor whether ROIC can sustain levels above its ten-quarter median as the balance sheet continues to accumulate cash.

A short DSO of 34 days alongside a DPO of 57 days suggests CF collects receivables quickly while leveraging supplier terms, a combination that limits cash tied up in operations. The inventory days of 34 are moderate, consistent with a commodity producer that prices and ships product on tight cycles. The low asset turnover, however, indicates that the plant base, rather than working capital, is the dominant driver of capital employed, which warrants continued scrutiny of asset productivity.

A debt-to-EBITDA of 3.91x in 2026Q3 is within a range that would typically be considered manageable for an industrial producer, though it has drifted from the 5.44x peak in 2024Q3. The steady decline in leverage metrics suggests deleveraging has been a deliberate priority alongside buybacks. Based on the supplied data, covenant headroom cannot be assessed, so investors should treat the absence of that disclosure as a gap rather than a signal of risk.